Study on Orbital Atherectomy for Critical Limb-Threatening Ischemia Launched in Europe
The ORACLE study will evaluate the effectiveness of orbital atherectomy in patients with critical limb-threatening ischemia across Europe.
Company
Pharmaceutical intelligence for Abbott with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.